Page last updated: 2024-08-23

pravastatin and 2,3-dinor-thromboxane b2

pravastatin has been researched along with 2,3-dinor-thromboxane b2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barrow, SE; Benjamin, N; Brassfield, T; Ritter, JM; Stratton, PD	1

Trials

1 trial(s) available for pravastatin and 2,3-dinor-thromboxane b2

Article	Year
Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease. British journal of clinical pharmacology, 1991, Volume: 32, Issue:1 Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Coronary Disease; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Platelet Activation; Pravastatin; Risk Factors; Thromboxane B2	1991

Article

Year

Reduction of LDL cholesterol by pravastatin does not influence platelet activation in patients with mild hypercholesterolaemia at risk of coronary heart disease.

British journal of clinical pharmacology, 1991, Volume: 32, Issue:1

Topics: Aged; Anticholesteremic Agents; Cholesterol, LDL; Coronary Disease; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Naphthalenes; Platelet Activation; Pravastatin; Risk Factors; Thromboxane B2

1991